4th Quarter - Report

FIERCE, ISAKOWITZ & BLALOCK for WATSON PHARMACEUTICALS

Firm
Client
Income
$15,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 239: Preserve Access to Affordable Generics Act

LobbyistCovered position, as disclosed
WILLIAM KIRK BLALOCK Deputy Director of Public Liason, The White House
KIRSTEN CHADWICK Special Assistant to the President for Legislative Affairs
MICHAEL CHAPPELL Special Projects Director, Rep. Pickering
KATE HULL Legislative Staff, Senator Bill Cohen
MARK WARREN ISAKOWITZ Press Secretary for Congressman Paul Gilmor
ALEIX JARVIS Staff Assistant, Congressman Charles Taylor

Contacted: SENATE

Bills named: S. 239 (111th)

Medicare/Medicaid MMM

Medicare Drug Reimbursement Policy

LobbyistCovered position, as disclosed
WILLIAM KIRK BLALOCK Deputy Director of Public Liason, The White House
KIRSTEN CHADWICK Special Assistant to the President for Legislative Affairs
MICHAEL CHAPPELL Special Projects Director, Rep. Pickering
KATE HULL Legislative Staff, Senator Bill Cohen
MARK WARREN ISAKOWITZ Press Secretary for Congressman Paul Gilmor
ALEIX JARVIS Staff Assistant, Congressman Charles Taylor

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.